市場調查報告書
商品編碼
422709

臉部注射劑市場預測:各類型 (玻尿酸,膠原蛋白,肉毒桿菌,聚合物·粒子),各用途 (臉部手術,臉部拉提),各終端用戶,各地區

Facial Injectible Market: By Type (Hyaluronic Acid, Collagen, Botulinum Toxin, Polymers & Particles); By Application (Facial Surgery, Facial Uplift); By End Users (Hospitals, Clinics, Research and Development Facilities) & By Region-Forecast 2019-2024

出版日期: | 出版商: IndustryARC | 英文 | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球臉部注射劑市場相關調查分析,提供市場形勢,市場動態,策略性分析,市場分析 (各市場區隔),再加上市場熵,主要企業等系統性資訊。

第1章 臉部注射劑市場:概要

第2章 摘要整理

第3章 臉部注射劑市場:形勢

  • 市場佔有率分析
  • 比較分析
  • 產品基準
  • 終端用戶分析
  • 5大財務分析

第4章 臉部注射劑市場:動態

  • 推動因素
  • 阻礙因素
  • 機會
  • 課題
  • 波特的五力分析

第5章 臉部注射劑市場:策略性分析

  • 價值鏈分析
  • 價格分析
  • 機會分析
  • 產品/市場生命週期分析
  • 供應商和經銷商

第6章 臉部注射劑市場:各類型

  • 玻尿酸
  • 膠原蛋白
  • 肉毒桿菌
  • 聚合物·粒子
  • 其他

第7章 臉部注射劑市場:各用途

  • 臉部手術
  • 臉部拉提
  • 其他

第8章 臉部注射劑市場:各終端用戶

  • 醫院
  • 診所
  • 研究開發設施

第9章 臉部注射劑市場:各地區

  • 歐洲
  • 亞太地區
  • 北美
  • 其他

第10章 臉部注射劑市場:熵

  • 產業擴大
  • 技術開發
  • M&A,合資企業
  • 供給契約

第11章 企業簡介

  • Bloomega BioTechnology Corporation Limited
  • Allergan Inc
  • Merz Pharma
  • Ipsen
  • Valeant Pharmaceuticals
  • Galderma
  • Integra Lifesciences
  • Tei Biosciences
  • Fibrogen
  • Ethicon

第12章 附錄

目錄

Facial Injectible, also commonly known as Dermal Fillers, are the products used for aesthetic purposes such as anti-aging and enhancing the appearance of facial skin and help in a trending application known as bio-engineering or facial rejuvenation. As humans age, the facial skin is bound to lose subcutaneous fat naturally, the skin is lured closer to the facial working muscles. Hence, smile lines and wrinkles over the face become more visible. Globally, an increasing aged population pool and increasing spending on healthcare are expected to be the key driving factors for the facial injectible market during the period of study.

Geographically, North America dominated the facial injectible market driven by a high number of aged and adult population, higher awareness, higher spending on such treatment, presence of world class infrastructure and service providers and stringent guidelines in the region. North America was followed by Europe and Asia-Pacific as second and third largest market for the facial injectible market. Asia Pacific is projected to have the fastest growth, owing to a rapidly developing healthcare infrastructure and rising healthcare spending in developing nations such as China and India in this region.

This report identifies the facial injectible market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the facial injectible market.

This report segments the facial injectible market on the basis of type, application, end-user and regional market as follows:

Facial Injectible market research report is classified on the basis of type. Some of the major types covered in this report are as follows: Hyaluronic Acid, Collagen, Botulinum Toxin, Polymers & Particles and Others

Facial Injectible market research report is classified on the basis of application. Some of the major applications covered in this report are as follows: Facial Surgery, Facial Uplift and Others

Facial Injectible market research report is classified on the basis of end-users. Some of the major end-users covered in this report are as follows: Hospitals, Clinics, Research and Development Facilities

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the facial injectible market. Some of the major companies' profiles in detail are as follows:

Bloomega BioTechnology Corporation Limited

Allergan Inc (Ireland)

Merz Pharma (Germany)

Ipsen (France)

Valeant Pharmaceuticals (Canada)

Table of Contents

1. Facial Injectible Market - Overview

2. Executive Summary

3. Facial Injectible Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
  • 3.3. Product Benchmarking
  • 3.4. End User Profiling
  • 3.5. Top 5 Financials Analysis

4. Facial Injectible Market- Forces

  • 4.1. Drivers
    • 4.1.1. Increasing Adoption of Augmented Reality Devices
    • 4.1.2. Compact size of facial injectible
  • 4.2. Restraints
  • 4.3. Opportunities
  • 4.4. Challenges
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Degree of Competition

5. Facial Injectible Market- Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunities Analysis
  • 5.4. Product/Market Life Cycle Analysis
  • 5.5. Suppliers and Distributors

6. Facial Injectible Market, By Type

  • 6.1. Hyaluronic Acid
  • 6.2. Collagen
  • 6.3. Botulinum Toxin
  • 6.4. Polymers & Particles
  • 6.5. Others

7. Facial Injectible Market, By Application

  • 7.1. Facial Surgery
  • 7.2. Facial Uplift
  • 7.3. Others

8. Facial Injectible Market, By End-User

  • 8.1. Hospitals
  • 8.2. Clinics
  • 8.3. Research & Development Facilities

9. Facial Injectible Market, By Geography

  • 9.1. Europe
    • 9.1.1. Germany
    • 9.1.2. France
    • 9.1.3. Italy
    • 9.1.4. Spain
    • 9.1.5. Russia
    • 9.1.6. U.K.
    • 9.1.7. Rest of Europe
  • 9.2. Asia Pacific
    • 9.2.1. China
    • 9.2.2. India
    • 9.2.3. Japan
    • 9.2.4. South Korea
    • 9.2.5. Rest of Asia-Pacific
  • 9.3. North America
    • 9.3.1. U.S.
    • 9.3.2. Canada
    • 9.3.3. Mexico
  • 9.4. Rest of the World (RoW)
    • 9.4.1. Brazil
    • 9.4.2. Rest of RoW

10. Facial Injectible Market - Entropy

  • 10.1. Expansion
  • 10.2. Technological Developments
  • 10.3. Merger & Acquisitions, and Joint Ventures
  • 10.4. Supply- Contract

11. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

  • 11.1. Bloomega BioTechnology Corporation Limited
  • 11.2. Allergan Inc (Ireland)
  • 11.3. Merz Pharma (Germany)
  • 11.4. Ipsen (France)
  • 11.5. Valeant Pharmaceuticals (Canada)
  • 11.6. Galderma (Switzerland)
  • 11.7. Integra Lifesciences (Us)
  • 11.8. Tei Biosciences
  • 11.9. Fibrogen (Finland)
  • 11.10. Ethicon (Us).

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

12. Appendix

  • 12.1. Abbreviations
  • 12.2. Sources
  • 12.3. Research Methodology
  • 12.4. Bibliography
  • 12.5. Compilation of Expert Insights
  • 12.6. Disclaimer